How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Colorectal Cancer

Select Clinical Trial

Colorectal Cancer

NSABP C-13 (ARGO): A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer

  • Men and women, ages 18 and older, diagnosed with Stage IIIB or IIIC colon cancer. For more information, please contact the study coordinator at 910-715-2200.


Clara McLean House
Make a Donation
News & Events